A Food and Drug Administration advisory panel on Wednesday endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer, concluding that the benefits of th�...
SAN FRANCISCO Noubar Afeyan, one of biotechs top investors, warned in an annual letter that a backlash against science in the U.S. could endanger U.S. life expectancy, take a sledgehammer to biotech �...
SAN FRANCISCO On Sunday, Alnylam, the gene-silencing company that notched one gigantic accomplishment after another over the past five years, set out a plan for the next five years built on yet more...
It has been a tough year for medicine. The U.S. research enterprise has been scrambled by a series of political decisions with long-reaching consequences. But make no mistake: Science didnt stop, and�...
Robert F. Kennedy Jr.s unilateral decision that the Centers for Disease Control and Prevention would no longer recommend Covid-19 boosters for healthy people during childhood or pregnancy represents �...